pharma stocks

NEW DELHI: Foreign brokerage Jefferies has initiated coverage on Gland Pharma and with buy ratings. It has a target of Rs 4,566 on Gland Pharma, valuing the stock at 36.5 times FY24 EPS, in line with its historical one-year forward of 37…

Though less known, India is also famous for its high quality and cheap medicines. As per data from the department of pharmaceuticals, India’s cost of manufacturing pharma products is 33% lower than western nations.…